Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed)
Department of Health and Human Services National Institutes of Health
Posted on:
Date limite d´inscription:
Expired
Type
Research/project funding
Reference Number
PAR-20-158
The purpose of this Funding Opportunity Announcement (FOA) is to support high risk, high impact, early discovery research on vaccine approaches to prevent acquisition of or ongoing infection by HIV. In keeping with the high risk, high impact nature of this research, this FOA supports a Go/No-Go approach to funding high risk research, which is significantly different from most R01 projects. Continued funding for the full award duration is dependent upon achieving negotiated Go/No-Go criteria by the end of Year 2.
Categories: Health.
Categories: Health.
États-Unis